Stromal Vascular Fraction Versus Nano fat therapy in Osteoarthritis knee

Comparative Outcome Analyses Of Stromal Vascular Fraction Versus Nanofat Therapy In Primary Osteoarthritis Knee - A Double-Blind Randomized Controlled Trial - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064076

Enrollment

Registered

2024-03-13

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M170- Bilateral primary osteoarthritis of knee

Interventions

Intervention1: Stromal Vascular Fraction: Nanofat therapy Intervention2: Stromal Vascular fraction: Stromal Vascular fraction obtained from autologous adipose tissue - 5 – 6 ml [cellular dosage of 5.0

Eligibility

Inclusion criteria

Inclusion criteria: Patients with radiological primary osteoarthritis of knees (Kellgren Lawrence grade 2 & 3 based on x-ray findings)

Exclusion criteria

Exclusion criteria: Patients with local infection at the site of the procedure, HIV, Hepatitis B or C, septicemia, other systemic metabolic disorders, bleeding, and other coagulation disorders

Design outcomes

Primary

Measure	Time frame
To compare the level of pain relief of stromal vascular fraction and nanofat in knee osteoarthritisTimepoint: at the end of 1, 3, 6, and 12 months	—

Secondary

Measure	Time frame
To assess the functional outcome of stromal vascular fraction & nanofat in knee osteoarthritisTimepoint: At the end of 1, 3, 6, & 12 months;To study the quantitative & qualitative imaging of cartilage regeneration following the therapyTimepoint: At end of 12 months	—

Countries

India

Contacts

Public ContactNaveen Jeyaraman

Mothercell Regenerative Centre

drvrraviortho@gmail.com9842426141

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026